中國醫藥大學機構典藏 China Medical University Repository, Taiwan:

浏览

邻近类别

	博碩士論文 [47/47]
	專利 [0/1]
	專書 [0/2]
	會議論文 [39/70]
	研究計畫 [99/152]

上传排行

数据加载中.....

下载排行

数据加载中.....

跳至: [中文] [数字0-9] [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ]

请输入前几个字:

显示项目1-50 / 284. (共6页)
1 2 3 4 5 6 > >>
每页显示[10|25|50]项目

日期	题名	作者
2009	14-3-3z Cooperates with ErbB2 to Promote Ductal Carcinoma In Situ Progression to Invasive Breast Cancer by Inducing Epithelial-Mesenchymal Transition	(Lu, J,); (Guo, H); (Treekitkarnmongkol, W); (Li, P.); (Zhang, J); (Shi, B); (Ling C); (Zhou, X); (Chen, T); (Chiao, P); (Feng X); (Seewaldt, V); (Muller, W); (Sahin, A); 洪明奇(Mien-Chie Hung); (Yu, D)*
2011-01	Acetylation of EGF receptor contributes to tumor cell resistance to histone deacetylase inhibitors.	(Song, H.); (Li, C-W.); (LaBaff, A. M.); (Lim, S-O.); 李龍緣(Long-Yuan Li); (Kan, S-F.); (Chen, Y.); (Zhang, K.); (Lang, J-Y.); (Xie, X.); (Wang, Y.); (Huo, L-F.); (Hsu, S-C.); (Chen, X-M.); (Zhao, Y-M.); 洪明奇(Mien-Chie Hung)*
2010	Activation of FOXO3a Is Sufficient to Reverse Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Q3 Kinase Inhibitor Chemoresistance in Human Cancer.	(Yang, JY); (Chang, CJ); (Xia, W); (Wang, Y.); (Wong, KK); (Engelman, J.A); (Du, Y.); (Andreeff, M); (Hortobagyi, G.N.); 洪明奇(Mien-Chie Hung)*
2014-11	Activation of Keap1/Nrf2 signaling pathway by nuclear epidermal growth factor receptor in cancer cells	(Longfei Huo); (Chia-Wei Li); (Tzu-Hsuan Huang); (Yung Carmen Lam); (Weiya Xia); (Chun Tu); 張為超(Wei-Chao Chang); (Jennifer L Hsu); (Dung-Fang Lee); (Lei Nie); (Hirohito Yamaguchi); (Yan Wang); (Jingyu Lang); 李龍緣(Long-Yuan Li); (Chung-Hsuan Chen); (Lopa Mishra); 洪明奇(Mien-Chie Hung)*
2009-10	The activation of matrix metalloproteinase-2 induced by protein kinase C alpha in decidualization.	蔡仁祥(Jen-Hsiang Tsai); 黃俊銘(Jin-Ming Hwang); 應宗和(Tsung-Ho Ying); 徐志誠(Jyh-Cherng Shyu); 蔡金秋(Chin-Chiu Tsai); 謝易修(Yih-Shou Hsieh); 王意維(Yi-Wei Wang); 劉哲育(Liu Jer-Yuh); 高紹軒(Shao-Hsuan Kao)
2010	Activation of MDM2 by Akt in mammary epithelium accelerates mammary tumorigenesis	(Xiaoyun Cheng); (Weiya Xia); (Jer-Yen Yang); (Jennifer L. Hsu); (Jing-Yu Lang); (Chao-Kai Chou); (Yi Du); (Hui-Lung Sun); (Shannon L. Wyszomierski); (Gordon B. Mills); (William J. Muller); (Dihua Yu); 洪明奇(Mien-Chie Hung)*
2010	Activation of p21(CIP1/WAF1) in mammary epithelium accelerates mammary tumorigenesis and promotes lung metastasis.	(Cheng, X.); (Xia, W.); (Yang, J-Y.); (Hsu, J-L.); (Chou, C-K.); (Sun, H-L); (Wyszomierski, S. L); (Mills, G. B); (Muller, W. J.); (Yu, D); 洪明奇(Mien-Chie Hung)*
2008-02	Activation of phosphoinositide 3-kinase by the NBS1 DNA repair protein through a novel activation motif	陳彥聰(Yen-Chung Chen); (Hsiu-Yin Chiang); 楊慕華(Muh-Hwa Yang); 陳博明(Po-Min Chen); 張學逸(Shyue-Yih Chang); 鄧述諄(Shu-Chun Teng); (Bart Vanhaesebroeck); 吳國瑞(Kou-Juey Wu)*
2010	Adenovirus 5E1A enhances histone deacetylase inhibitors-induced apoptosis through Egr-1-mediated Bim upregulation.	(Yamaguchi H); (Chen CT); (Chou CK); (Pal A); (Bornmann W); (Hortobagyi); 洪明奇(Mien-Chie Hung)*
2005-05	Amplification and Overexpression of Prosaposin in Prostate Cancer	(Shahriar Koochekpour)*; (Yujun Zhang); (Rameen Beroukhim); è¬åç²; (Matthias D. Hofer); (Haiyen E. Zhau); (Masao Hiraiwa); (Daniel Y. Pattan); (Joy L.Ware); (Ronald B. Luftig); (Konrad Sandhoff); (Charles L. Sawyers); (Kenneth J. Pienta); (Mark A. Rubin); (Robert L. Vessella); (William R. Sellers); (Oliver Sartor)
2001-06	Analysis of mechanisms associated with loss of infectivity of clonal populations of Borrelia burgdorferi B31MI	(McDowell, J. V.); 宋賢穎(Shian-Ying Sung); (Labandeira-Rey, M.); (Skare, J. T.); (Marconi, R. T.)*
2010-12	Analysis of oligo-arginine cell-permeable peptides uptake by prostate cells	(Jian Zhou); (Wei Liu); (Rey-Chen Pong); (Guiyang Hao); (Xiankai Sun); 謝哲宗(Jer-Tsong Hsieh)
1998-03	Analysis of the organization of multicopy linear- and circular-plasmid-carried open reading frames in Borrelia burgdorferi sensu lato isolates	(Carlyon, J. A.); (LaVoie, C.); 宋賢穎(Shian-Ying Sung); (Marconi, R. T.)*
2013-03	Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility	(34. Kuo TC); (Tan CT); (Chang YW); (Hong CC); (Lee WJ); (Chen MW); (Jeng YM); (Chiou J); (Yu P); (Chen PS); (Wang MY); (Hsiao M); 蘇振良(Jen-Liang Su); (Kuo ML)
2013-12	Antioxidant and Cytoprotective Activities of Ocimum Gratissimum Extracts against Hydrogen Peroxide Induced Toxicity in Human HepG2 Cells	(YUNG-WEI CHIU); (HUNG-JEN LO); (HSIN-YU HUANG); (PEI-YU CHAO); (JIN-MING HWANG); (PEI-YUN HUANG); (SHYH-JER HUANG); 劉哲育(Liu Jer-Yuh); (TE-JEN LAI)
2014-07	Antitumor Activity of Acriflavine in Human Hepatocellular Carcinoma Cells	(CHIA-JEN LEE); (CHIA-HERNG YUE); 林俞佑(YU-YU LIN); (JAW-CHING WU); 劉哲育(Liu Jer-Yuh)
2014-11	Antitumor Activity of Acriflavine in Lung Adenocarcinoma Cell Line A549	(CHIA-JEN LEE); (CHIA-HERNG YUE); (YU-JIE LIN); (YU-YU LIN); (SHAO-HSUAN KAO); 劉哲育(Liu Jer-Yuh); (YIENG-HOW CHEN)*
2010	Antitumor agents 270. Novel substituted 6-phenyl-4H-furo[3,2-c]pyran-4-one derivatives as potent and highly selective anti-breast cancer agents.	(Dong Y,); (Shi Q); (Nakagawa-Goto K,); (Wu PC); (Morris-Natschke SL); (Brossi A,); (Bastow, KF,); (Lang JY); 洪明奇(Mien-Chie Hung); (Lee, KH)*
2010-02	Antitumor Agents. 272. Structure-Activity Relationships and In Vivo Selective Anti-Breast Cancer Activity of Novel Neo-tanshinlactone Analogues	(Dong Y); (Shi Q); (Pai HC); (Peng CY); (Pan SL); (Teng CM); (Nakagawa-Goto K); (Yu D); (Liu YN); (Wu PC); (Bastow KF); (Morris-Natschke SL); (Brossi A); (Lang JY); (Hsu JL); 洪明奇(Mien-Chie Hung); (Lee EY); (Lee KH)*
2010	Antitumor agents. 282. 2'-(R)-O-acetylglaucarubinone, a quassinoid from Odyendyea gabonensis as a potential anti-breast and anti-ovarian cancer agent	(Usami, Y); (Nakagawa-Goto, K); (Lang, J-Y); (Kim, Y.); (Lai, C-Y); (Goto, M.); (Sakurai, N.); (Taniguchi, M); (Akiyama, T.); (Morris-Natschke, S. L.); (Bastow, K. F.); (Cragg, G.); (Newman, D.J.); (Fujitake, M.); (Takeya, K.); 洪明奇(Mien-Chie Hung); (Lee, E. Y-H. P.); (Lee, K-H.)*
2010	ARD1 Stabilization of TSC2 Suppresses Tumorigenesis Through the mTOR Signaling Pathway	(Kuo, H-P); (Lee, D-F); (Chen, C-T.); (Liu, M.); (Chou, C-K.); (Lee, H. J.); (Xie, X.); (Wei, Y.); (Xia, W); (Zhang, W.); (Yi, D.); (Yang, J-Y.); (Huang, T-H); (Yen, C-J.); (Tan, M); (Xing, G); (Zhao, Y); (Lin, C-H); (Tsai, S-F); (Fidler, I. J.); 洪明奇(Mien-Chie Hung)*
2010	ARD1 stalization of TSC2 suppresses tumorigenesis via the mTOR signaling pathway	(Kuo, H-P); (Lee, D-F); (Chen, C-T.); (Liu, M.); (Chou, C-K.); (Lee, H. J.); (Xie, X.); (Wei, Y.); (Xia, W); (Zhang, W.); (Yi, D.); (Yang, J-Y.); (Huang, T-H); (Yen, C-J.); (Tan, M); (Xing, G); (Zhao, Y); (Lin, C-H); (Tsai, S-F); (Fidler, I. J.); 洪明奇(Mien-Chie Hung)*
2010-04	Aromatase Deficiency Inhibits the Permeability Transition in Mouse Liver Mitochondria	(Loredana Moro); (Arnaldo A. Arbini); 謝哲宗(Jer-Tsong Hsieh); (Jeffery Ford); (Evan R. Simpson); (Asghar Hajibeigi); (Orhan K. Oz)
2010	Arrest-defective-1 protein (ARD1): tumor suppressor or oncoprotein	(Kuo, H-P); 洪明奇(Mien-Chie Hung)*
2014-08	ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1	(Zhang, P.); (Wei, Y.); (Wang, L.); (Debeb, B. G.); (Yuan, Y.); (Zhang, J.); (Yuan, J.); (Wang, M); (Chen, D.); (Sun, Y.); (Woodward, W. A.); (Liu, Y.); (Dean, D. C.); (Liang, H.); (Hu, Y.); (Ang, K); 洪明奇(Mien-Chie Hung); (Chen, J.); (Ma, L.)*
2010	Aurora Kinase A Promotes Ovarian Tumorigenesis through Dysregulation of the Cell Cycle and Suppression of BRCA2.	(Yang G); (Chang B); (Yang F); (Guo X); (Cai KQ); (Mercado-Uribe I); (Xiao X); (Wang H); (Sen S); 洪明奇(Mien-Chie Hung); (Mills GB); (Chang S,); (Multani A); (Liu J)*
2006-09	B2-Microglobulin Is a Signaling and Growth-Promoting Factor for Human Prostate Cancer Bone Metastasis	(Wen-Chin Huang); (Daqing Wu); (Zhihui Xie); (Haiyen E. Zhau); (Takeo Nomura); (Jan Pohl); 謝嘉玲; (M. Neale Weitzmann); (Mary C. Farach-Carson); (Leland W.K. Chung)*
2013-12	BCRP/ABCG2 Inhibition Sensitizes Hepatocellular Carcinoma Cells to Sorafenib	黃偉謙(Wei-Chien Huang); (Yi-Ling Hsieh); (Chao-Ming Hung); (Pei-Hsuan Chien); (Yu-Fong Chien); (Lei-Chin Chen); 涂智彥(Chih-Yen Tu); 陳家弘(Chia-Hung Chen); (Sheng-Chieh Hsu); (Yueh-Ming Lin); (Yun- Ju Chen)*
2008-04	Bile Acid Exposure Up-regulates Tuberous Sclerosis Complex 1/Mammalian Target of Rapamycin Pathway in Barrett's-Associated Esophageal Adenocarcinoma	(Chia-Jui Yen); (Julie G. Izzo); (Dung-Fang Lee); (Sushovan Guha); (Yongkun Wei); (Tsung-Te Wu); (Chun-Te Chen); (Hsu-Ping Kuo); (Jung-Mao Hsu); (Hui-Lung Sun); (Chao-Kai Chou); (Navtej S. Buttar); (Kenneth K. Wang); (Peng Huang); (Jaffer Ajani); 洪明奇(Mien-Chie Hung)*
2010-03	Blockade of Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase and Murine Double Minute Synergistically Induces Apoptosis in Acute Myeloid Leukemia via BH3-Only Proteins Puma and Bim.	(Zhang W); (Konopleva M); (Burks JK); (Dywer KC); (Schober WD); (Yang JY,); (McQueen TJ); 洪明奇(Mien-Chie Hung); (Andreeff M)*
2016-02	Blocking c-Met-mediated PAPR1 phosphorylation enhances anti-tumor effects of PARP inhibitors	(Du, Y.); (Yamaguchi, H.); (Wei, Y.); (Hsu, J. L.); (Wang, H-L.); (Hsu, Y-H.,); (Lin, W-C.); (Yu, W-H.); (Leonard, P. G.); (Lee, G-R. IV); (Chen, M-K.); (Nakai, K.); (Hsu, M-C.); (Chen, C-T.); (Sun, Y.); (Wu, Y.); 張為超(Wei-Chao Chang); (Huang, W-C.); (Liu, C-L.); (Chang, Y-C.); (Chen, C-H.); (Park, M.); (Jones, P.); (Hortobagyi, G. N.); 洪明奇(Mien-Chie Hung)*
2010-10	Bmi1 is essential in Twist1-induced epithelial–mesenchymal transition	楊慕華(Muh-Hwa Yang); 許信翔(Dennis Shin-Shian Hsu); 王學偉(Hsei-Wei Wang); 王曉蓉(Hsiao-Jung Wang); (Hsin-Yi Lan); 楊文豪(Wen-Hao Yang); 黃奇宏(Chi-Hung Huang); 高壽延(Shou-Yen Kao); 曾成槐(Cheng-Hwai Tzeng); 戴世光(Shyh-Kuan Tai); 張學逸(Shyue-Yih Chang); 李光申(Oscar Kuang-Sheng Lee); 吳國瑞(Kou-Juey Wu)
2009	Cancer targeted gene therapy of BikDD inhibits orthotopic lung cancer growth and improves long-term survival	佘玉萍(Yuh-Pyng Sher); (Tz-Fei Tzeng); (Shu-Fen Kan); (Jennifer Hsu); (Xiaoming Xie); (Zhenbo Han); 林文川(Wen-Chuan Lin); 李龍緣(Long-Yuan Li); 洪明奇(Mien-Chie Hung)
2012-07	Cancer-associated carbohydrate antigens as potential biomarkers for hepatocellular carcinoma	(Chen-Shiou Wu); (Chia-Jui Yen); 鄒瑞煌(Ruey-Hwang Chou); (Shiou-Ting Li); 黃偉謙(Wei-Chien Huang); (Chien-Tai Ren); (Chung-Yi Wu); 余永倫(Yung-Luen Yu)
2011-04	Cancer-targeted gene therapy elicits protective anti-tumor immunity against lung cancer metastasis. Molecular Cancer Therapeutics.	佘玉萍(Yuh-Pyng Sher); 劉士任(Shih-Jen Liu); (Chang CM); (Lien SP); (Chen CH); (Han Z); 李龍緣(Long-Yuan Li); (Chen JS); (Wu CW); 洪明奇(Mien-Chie Hung)*
2015-11	Carglumic acid promotes apoptosis and suppresses cancer cell proliferation in vitro and in vivo	(335. Chen, C-T.); (Chen, Y-C.); (Yamaguchi, H.); 洪明奇(Mien-Chie Hung)*
2015-07	CARMA3 Represses Metastasis-Suppressor NME2 to Promote Lung Cancer Stemness and Metastasis	(Chang YW,); (Chiu CF); (Lee KY); (Hong CC); (Wang YY); (Cheng CC); (Jan YH); (Huang MS); (Hsiao M); (Ma JT); 蘇振良(Jen-Liang Su)*
2014-06	CCL5/RANTES is important for inducing osteogenesis of human mesenchymal stem cells and is regulated by dexamethasone	(Liu YC); (Kao YT); (Huang WK); (Lin KY); (Wu SC); (Hsu SC); (Schuyler SC); 李龍緣(Long-Yuan Li); (Leigh Lu F); (Lu J)*
2011-01	CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells	(Yongkun Wei); 陳雅惠(Ya-Huey Chen); 李龍緣(Long-Yuan Li); (Jingyu Lang); 葉士芃(Su-Peng Yeh); (Bin Shi); (Cheng-Chieh Yang); (Jer-Yen Yang); (Chun-Yi Lin); (Chien-Chen Lai); 洪明奇(Mien-Chie Hung)
2011-01	CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells	(Yongkun Wei); 陳雅惠(Ya-Huey Chen); 李龍緣(Long-Yuan Li); (Jingyu Lang); 葉士芃(Su-Peng Yeh); (Bin Shi); (Cheng-Chieh Yang); (Jer-Yen Yang); (Chun-Yi Lin); (Chien-Chen Lai); 洪明奇(Mien-Chie Hung)
2001-07	The cellular protein PRA1 modulates the anti-apoptotic activity of Epstein-Barr virus BHRF1, a homologue of Bcl-2, through direct interaction.	李龍緣(Long-Yuan Li); (Hsiu-Ming Shih); (Mei-Ying Liu); (Jen-Yang Chen)
2004-02	Characterization of a novel monoclonal antibody to the BHRF1 protein of Epstein-Barr virus	(Sheng-Ping Chou); (Ching-Hwa Tsai); 李龍緣(Long-Yuan Li); (Mei-Ying Liu); (Jen-Yang Chen)*
2015-10	CHD1L Regulated PARP1-Driven Pluripotency and Chromatin Remodeling During the Early-Stage Cell Reprogramming	(Bo-Hua Jiang); (Wei-Yi Chen); (Hsin-Yang Li); (Yueh Chien); 張為超(Wei-Chao Chang); (Pei-Chen Hsieh); (Ping Wu); (Chieh-Yu Chen); (Hui-Yung Song); (Chian-Shiu Chien); (Yen-Jen Sung); (Shih-Hwa Chiou)*
2013-01	Chloride intracellular channel 4 involves in the reduced invasiveness of cancer cells treated by photodynamic therapy.	(Chiang PC); 鄒瑞煌(Ruey-Hwang Chou); (Chien HF); (Tsai T); (Chen CT)*
2013-06	The circulating level of MMP-9 and its ratio to TIMP-1 as a predictor of severity in patients with community-acquired pneumonia	(Ting-Yen Chiang); 余永倫(Yung-Luen Yu); (Chiao-Wen Lin); (Shih-Ming Tsao); (Shun-Fa Yang); (Chao-Bin Yeh)*
2011-01	CKD1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells	(Yongkun Wei); 陳雅惠(Ya-Huey Chen); 李龍緣(Long-Yuan Li); (Jingyu Lang); 葉士芃(Su-Peng Yeh); (Bin Shi); (Cheng-Chieh Yang); (Jer-Yen Yang); (Chun-Yi Lin); 賴建成(Chien-Chen Lai); 洪明奇(Mien-Chie Hung)
2008-12	Coevolution of Prostate Cancer and Bone Stroma in Three-Dimensional Coculture: Implications for Cancer Growth and Metastasis	宋賢穎(Shian-Ying Sung); 謝嘉玲(Chia-Ling Hsieh); (Andrew Law); (Haiyen E. Zhau); (Sen Pathak); (Asha S. Multani); (Sharon Lim); (Ilsa M. Coleman); 吳麗琴(Li-Chin Wu); (William D. Figg); (William L. Dahut); (Peter Nelson); (Jae K. Lee); (Mahul B. Amin); (Robert Lyles); (Peter A J Johnstone); (Fray F. Marshal); (Leland W. K. Chung)*
2008-12	Coevolution of Prostate Cancer and Bone Stroma in Three-Dimensional Coculture: Implications for Cancer Growth and Metastasis	宋賢穎(Shian-Ying Sung); 謝嘉玲(Chia-Ling Hsieh); (Andrew Law); (Haiyen E. Zhau); (Sen Pathak); (Asha S. Multani); (Sharon Lim); (Ilsa M. Coleman); 吳麗琴(Li-Chin Wu); (William D. Figg); (William L. Dahut); (Peter Nelson); (Jae K. Lee); (Mahul B. Amin); (Robert Lyles); (Peter A J Johnstone); (Fray F. Marshal); (Leland W. K. Chung)*
2012-12	The combination of dynamic alterations in urinary VEGF levels and tissue ADAM9 expression to predict lethal phenotypic progression of prostate cancer during hormone therapy and TURP	(Pen, CC); 劉哲銘(Liu, CM); (Lin, CC); (Lin, CC); (Hsieh, TF); (Josson, Sajni); (He, YC); (Chung, LWK); (Lin, KL); 宋賢穎(Shian-Ying Sung)*
2001-08	A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis.	(Shigeji Matsubara); (Yoshitaka Wada); (Thomas A. Gardner); (Masayuki Egawa); (Moon-Soo Park); 謝嘉玲; (Haiyen E. Zhau); (Chinghai Kao); (Sadao Kamidono); (Jay Y. Gillenwater); (Leland W. K. Chung)*

显示项目1-50 / 284. (共6页)
1 2 3 4 5 6 > >>
每页显示[10|25|50]项目

数据加载中.....

最近上传

上传排行

下载排行